ArticleJournal of clinical medicine2026
Hemoglobin Trajectories on SGLT2 Inhibitor Therapy in Heart Failure: Anemia Marks Adverse Prognosis While Erythrocytosis Is Transient and Not Associated with Adverse Outcomes.
Ivana Jurin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.